申请人:Velaparthi Upender
公开号:US20100197654A1
公开(公告)日:2010-08-05
The invention provides compounds of formula I
and pharmaceutically acceptable salts thereof.
The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents.
该发明提供了公式I的化合物及其药用盐。公式I的化合物抑制酪氨酸激酶活性,因此它们可用作抗癌药物。